Citadel Advisors
AHCO icon

Citadel Advisors’s AdaptHealth AHCO Stock Holding History

Citadel Advisors’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.05M Buy
484,652
+355,546
+275% +$3.97M ﹤0.01% 4712
2026
Q1 		$1.54M Buy
129,106
+54,056
+72% +$553K ﹤0.01% 6656
2025
Q4 		$747K Buy
+75,050
New +$717K ﹤0.01% 8063
2025
Q2 		– Sell
-310,004
Closed -$2.74M – 12358
2025
Q1 		$3.36M Buy
310,004
+173,602
+127% +$1.75M ﹤0.01% 4562
2024
Q4 		$1.3M Sell
136,402
-243,448
-64% -$2.46M ﹤0.01% 6509
2024
Q3 		$4.27M Buy
379,850
+77,621
+26% +$825K ﹤0.01% 4204
2024
Q2 		$3.02M Buy
+302,229
New +$3.07M ﹤0.01% 4552
2024
Q1 		– Sell
-22,130
Closed -$188K – 14482
2023
Q4 		$161K Sell
22,130
-155,721
-88% -$1.23M ﹤0.01% 10272
2023
Q3 		$1.62M Sell
177,851
-276,342
-61% -$3.31M ﹤0.01% 5606
2023
Q2 		$5.53M Sell
454,193
-663,488
-59% -$7.39M ﹤0.01% 3499
2023
Q1 		$13.9M Buy
1,117,681
+809,152
+262% +$14.9M ﹤0.01% 2376
2022
Q4 		$5.93M Sell
308,529
-101,789
-25% -$2.15M ﹤0.01% 3582
2022
Q3 		$7.71M Sell
410,318
-172,235
-30% -$3.54M ﹤0.01% 3145
2022
Q2 		$10.5M Sell
582,553
-185,385
-24% -$3.01M ﹤0.01% 2623
2022
Q1 		$12.3M Buy
767,938
+727,664
+1,807% +$13.1M ﹤0.01% 2642
2021
Q4 		$985K Sell
40,274
-182,987
-82% -$4.3M ﹤0.01% 7996
2021
Q3 		$5.2M Buy
223,261
+160,730
+257% +$3.89M ﹤0.01% 4223
2021
Q2 		$1.71M Sell
62,531
-61,229
-49% -$1.75M ﹤0.01% 6981
2021
Q1 		$4.55M Buy
123,760
+43,176
+54% +$1.53M ﹤0.01% 4454
2020
Q4 		$3.03M Sell
80,584
-72,410
-47% -$2.24M ﹤0.01% 4572
2020
Q3 		$3.34M Buy
152,994
+94,794
+163% +$1.99M ﹤0.01% 3807
2020
Q2 		$937K Buy
58,200
+47,825
+461% +$799K ﹤0.01% 5948
2020
Q1 		$166K Buy
+10,375
New +$147K ﹤0.01% 8191

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors's AHCO Position: Q2 2026 in Review

Citadel Advisors increased its AdaptHealth (AHCO) stake by 275% in Q2 2026, buying an estimated $3.97M and bringing the position to 484,652 shares worth $5.05M. The position accounts for ﹤0.01% of the portfolio, ranked #4712.

Citadel Advisors first reported a position in AHCO in Q1 2020 and has held it in 23 quarters since. The position peaked at $13.9M in Q1 2023. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Citadel Advisors held 484,652 shares of AdaptHealth worth $5.05M as of Q2 2026.
  • Citadel Advisors bought 355,546 AdaptHealth shares in Q2 2026, an estimated $3.97M.
  • AdaptHealth made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4712 holding.
  • Citadel Advisors first reported a position in AdaptHealth in Q1 2020 and has held it in 23 quarters since.
  • Citadel Advisors's AdaptHealth position peaked at $13.9M in Q1 2023.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.